Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias.

Barca, Emanuele; Emmanuele, Valentina; DiMauro, Salvatore; Toscano, Antonio; Quinzii, Catarina M

Barca, Emanuele; Emmanuele, Valentina; DiMauro, Salvatore; Toscano, Antonio; Quinzii, Catarina M.

Afiliação

Barca E; Department of Neurology, Columbia University Medical Center, New York, NY, 10032, United States.
Emmanuele V; Department of Clinical and Experimental Medicine, University of Messina, Messina, 98125, Italy.
DiMauro S; Department of Neurology, Columbia University Medical Center, New York, NY, 10032, United States.
Toscano A; Department of Clinical and Experimental Medicine, University of Messina, Messina, 98125, Italy.
Quinzii CM; Department of Neurology, Columbia University Medical Center, New York, NY, 10032, United States.

Curr Neuropharmacol ; 17(1): 21-32, 2019.

Article em En | MEDLINE | ID: mdl-29119930

Assuntos

Antioxidantes/uso terapêutico; Ataxia Cerebelar/tratamento farmacológico; Animais; Ataxia Cerebelar/metabolismo; Humanos; Estresse Oxidativo/efeitos dos fármacos

Palavras-chave

Antioxidants; ataxias; cerebellar ataxia; coenzyme Q10; idebenone; oxidative stress.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataxia Cerebelar / Antioxidantes Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google